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California.Introduction
Patients with congenital heart disease may be ideal candi-
dates for completely subcutaneous implantable cardioverter-
deﬁbrillator (S-ICD) systems because of the presence of
intracardiac shunts, limited venous access, and intracardiac
anatomy that may be contraindicated to transvenous
implantable cardioverter-deﬁbrillator (ICD) systems. How-
ever, even S-ICD systems may require nonstandard place-
ment because of anatomic abnormalities in patients with
complex congenital heart disease. We describe the place-
ment of an S-ICD on the right side of the thorax in a patient
with tetralogy of Fallot and dextrocardia and discuss the use
of S-ICDs in the pediatric and adult congenital heart disease
populations.Case report
The patient was a 21-year-old man with a history of
dextrocardia, tetralogy of Fallot, and Klinefelter syndrome.
His history was signiﬁcant for multiple cardiac surgeries and
sternotomies, including placement of a right modiﬁed BT
shunt in the newborn period, complete repair of tetralogy of
Fallot at age 1 year (ventricular septal defect closure, right
ventricular outﬂow tract [RVOT] patch augmentation,
resection of infundibular tissue in the RVOT), pulmonary
valve replacement with intraoperative cryoablation of the
right ventricle (RV)/RVOT due to ventricular tachycardia,KEYWORDS Subcutaneous implantable cardioverter-deﬁbrillator; Congenital
heart disease; Pediatrics; Tetralogy of Fallot; Dextrocardia
ABBREVIATIONS ATP ¼ antitachycardia pacing; ICD ¼ implantable
cardioverter-defibrillator; RV ¼ right ventricle; RVOT ¼ right
ventricular outflow tract; S-ICD ¼ subcutaneous implantable
cardioverter-defibrillator; VF ¼ ventricular fibrillation
(Heart Rhythm Case Reports 2015;1:186–189)
Address reprint requests and correspondence: Dr. Scott R. Ceresnak,
Pediatric Cardiology, Pediatric Electrophysiology, Department of Pediatrics,
Lucille Packard Children’s Hospital–Stanford University, 750 Welch Rd,
Suite 305, Palo Alto, CA 94304. E-mail address: ceresnak@yahoo.com.
2214-0271 B 2015 Heart Rhythm Society. Published by Elsevier Inc. This is an o
(http://creativecommons.org/licenses/by-nc-nd/4.0/).tricuspid valve annuloplasty, and modiﬁed right atrial maze
procedure because of recurrent atrial ﬂutter. Due to a history
of recurrent ventricular tachycardia and easily inducible
ventricular ﬁbrillation (VF) on a prior ventricular stimulation
study in the electrophysiology laboratory, he underwent
placement of a left-sided transvenous dual-chamber dual-
coil ICD at age 14 years. Deﬁbrillation safety testing at that
time failed, and the patient underwent placement of a
subcutaneous coil with resultant successful safety testing.
He subsequently developed severe pulmonary and tricuspid
regurgitation and most recently underwent repeat pulmonary
valve replacement (33-mm bioprosthetic), tricuspid valve
replacement (31-mm bioprosthetic), RVOT patch augmen-
tation, and planned removal of the transvenous ICD along
with placement of an epicardial dual-chamber ICD. During
this surgery, the sternum could not be fully opened because
of adhesion of the RVOT to the sternum. Therefore, he was
cannulated for bypass in the right femoral vessels. The
pulmonary and tricuspid valves were replaced without
incident, and the intracardiac portion of the transvenous
ICD system was partially removed. Before the epicardial
system could be completely implanted, however, there was
difﬁculty maintaining bypass ﬂow, and the abdomen was
found to be distended. The sternotomy was extended
inferiorly to a full laparotomy to relieve abdominal compart-
ment syndrome, and the patient was returned to the intensive
care unit with an open abdomen and chest. The abdomen and
chest were closed 3 days later, but the epicardial ICD system
was not placed at that time because of the patient’s recurrent
fevers and the concern for infection.
After the patient’s full surgical recovery there were
detailed discussions with the family and care team regard-
ing options for ICD placement. Because of the risks
associated with a repeat sternotomy and the concerns
with placing a new transvenous lead across the patient’s
new prosthetic tricuspid valve, we elected to place a right-
sided S-ICD. Considering the patient’s history of atrial
ﬂutter, which was responsive to antitachycardia pacingpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.02.001
KEY TEACHING POINTS
 Patients with congenital heart disease may be
ideal candidates for completely subcutaneous
implantable cardioverter-deﬁbrillator (S-ICD)
systems because of the presence of intracardiac
shunts, limited venous access, and intracardiac
anatomy that may be contraindicated to
transvenous ICD systems.
 S-ICDs can be placed in nonstandard locations
(eg, right thorax) and can be effective in children
and in patients with complex congenital heart
disease.
 S-ICDs can be used successfully in combination
with standard transvenous systems having
antitachycardia pacing capabilities in patients with
concomitant atrial arrhythmias.
 Careful screening, especially in patients with
conduction disease, in different positions and
with exercise is important before implantation.
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Figure 1 Representative screening electrograms through the programmer before
failed screening, 1 lead conﬁguration on the right side of the thorax passed the scgenerator to be used for future potential therapy for atrial
ﬂutter.
Detailed screening for the S-ICD was performed before
device placement. Baseline 12-lead ECG demonstrated
sinus rhythm with right bundle branch block and QRS
duration of 200 ms. Initial ECG vector screening revealed
that the patient would be an adequate candidate based on
screening with the generator in the right axilla and the coil
placed on the right of the sternum. Screening with the
generator in the left axilla and the coil to the left of the
sternum, as well as screening with the generator in the right
axilla and the coil to the left of the sternum, failed to meet
adequate sensing thresholds (Figure 1). Because of concern
about the patient’s risk for inappropriate shocks due to his
history of atrial ﬂutter and wide QRS duration, screening
was also performed on the treadmill and he passed the
screening at high heart rates.1
A Boston Scientiﬁc SQ-RX S-ICD (Boston Scientiﬁc, Marl-
borough, MA) was placed with the generator in the right axilla,
the inferior portion of the coil to the right of the xyphoid process
and the tip of the coil to the immediate right of the sternum with
careful attention to avoid having the tip of the coil touch a sternal
wire. Sensing through the device was noted to be best in the
alternate sensing mode (from inferior portion of the coil to the
generator). Sensing through the S-ICD was also checked with






device implantation. Although all screening electrograms on the left thorax
reening algorithm supine, standing, and with exercise.
Heart Rhythm Case Reports, Vol 1, No 4, July 2015188from the transvenous atrial lead to ensure there were no problems
with oversensing. Safety testing was performed in the electro-
physiology laboratory at the time of implantation. A 50-Hz burst
induced VF with adequate sensing and termination of VF with
restoration of sinus rhythm after 18 seconds from one 65-J shock.
His previously implanted transvenous system was left in place,
with only the transvenous atrial lead connected to the ICD
generator and programmed AAI at 60 bpm with the potential forFigure 2 Chest radiograph after subcutaneous implantable cardioverter-
deﬁbrillator (S-ICD) placement. Posteroanterior (A) and lateral (B) chest
x-ray ﬁlms in the patient with dextrocardia and tetralogy of Fallot after S-
ICD placement. Note the S-ICD generator in the right axilla and deﬁbrilla-
tion coil immediately to the right of the sternum (red arrow). A transvenous
atrial lead connected to the transvenous ICD system in the left delto-pectoral
area was left in place to provide atrial antitachycardia pacing (ATP) because
of the patient’s history of atrial ﬂutter that was responsive to ATP.future manual ATP because of his history of recurrent atrial
ﬂutter (Figure 2).
Discussion
The use of ICDs in children and young adults with
congenital heart disease has evolved over the past several
decades. Implantation of transvenous and epicardial systems
in these patients is not without long-term risks. The incidence
of lead fractures, inappropriate shocks, venous occlusion,
and infection seems to be higher in this population than in
adults and can be as high as 30%.2–4 In addition, many
patients cannot receive transvenous ICD systems because of
single-ventricle physiology, the presence of intracardiac
shunts, small patient size, and limited venous access to the
heart.5 Thus, placement of an S-ICD may provide an
excellent alternative to epicardial or transvenous systems in
a select group of these patients.
In this report, we describe the use of an S-ICD system on
the right side of the thorax in a young adult with a history of
dextrocardia and congenital heart disease. The S-ICD system
typically is placed in the left axilla, with the subcutaneous
coil positioned to the left of the sternum.6 There are currently
few reports in the literature on use of an S-ICD system in
nonstandard positions.7–11 In our patient, the S-ICD system
functioned appropriately and effectively with positioning of
the generator in the right axilla and the subcutaneous coil on
the right side of the chest. Deﬁbrillation safety testing also
revealed excellent sensing during VF and an adequate
deﬁbrillation safety margin on the right side of the thorax.
There are also few reports of placement of S-ICD systems
in children.12,13 Griksaitis et al14 reported on S-ICD use in 23
children, and Pettit et al13 reported on its use in 9 children (all
on the left side of the thorax), with no difference in rates of
pocket hematoma, infection, or inappropriate shocks com-
pared to standard transvenous systems. Use of an S-ICD in a
young patient who requires ICD placement is appealing
because it avoids the need for transvenous leads, thus
potentially averting venous occlusion and the notable risk
of lead extraction in the event of lead failure or fracture.15
Although the S-ICD cannot be used as sole therapy in a
patient requiring chronic pacing or ATP, we demonstrated in
this case that the S-ICD system can be used in conjunction
with a previously placed transvenous system that may still
provide ATP if needed. Thus, the S-ICD can be used
effectively in the right thorax in patients with complex
congenital heart disease and dextrocardia.
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